Antibacterial Agents TRIZ Cases

Lipophenolic resveratrol derivatives inhibit matrix metalloprotease-9, reducing vascular permeability in viral hemorrhagic fevers.

Merging diverse S. aureus antigens into one composition overcomes single-target vaccine limitations.

Novel fluorogenic substrates target BlaC enzyme activity to enable rapid tuberculosis detection via fluorescence-based assays.

Inert atmosphere lyophilization prevents oxidation, extending reconstitution times without low-temperature processing.

Combined mutation classes reduce vesicular stomatitis virus neurovirulence, resolving the conflict between robust replication and safety profiles.

Computational screening of compounds binding the flexible FlhB loop inhibits toxin secretion, bypassing complex experimental structure determination.

Pyrimidine compounds inhibit IL-12, IL-23, and IL-27 production to down-regulate Th1 and Th17 cell responses in autoimmune disorders.

High-pressure homogenization creates stable small molecule immune potentiator suspensions for vaccine delivery.

Ultrasonic segmentation reduces dihydromyricetin particle size below 300 nm, resolving poor water solubility and low bioavailability.

Segmented STAMPs target specific pathogens while sparing benign microflora, resolving broad-spectrum antibiotic trade-offs.

Fused imidazole compounds reduce pro-inflammatory products and immune cell activation by blocking SSAO enzyme activity.

A liposome formulation containing Mycobacterium tuberculosis fragments and sucrose achieves enhanced bioavailability through controlled particle size reduction.

A multi-component composition disrupts bacterial biofilms and prevents adhesion using natural extracts.

Administering a gastrointestinal cleanser before rifaximin improves treatment durability by reducing bacterial load, though it increases protocol complexity.

A eosinophil peroxidase composite with glycine and L-proline enhances microbiocidal activity against pathogens.

Non-toxigenic Protein A variants stimulate protective immunity against Staphylococcus aureus without triggering toxic immunoglobulin binding.

Engineered IdeS variants reduce immunogenicity and anti-drug antibody formation, enabling safe therapeutic use for autoimmune diseases.

N-(Phosphonoalkyl)-amino acid compounds alleviate skin aging, pain, and inflammation by bridging preclinical data with regulatory approval pathways.

Formula I heteroaryl compounds selectively inhibit IRAK-4 and IRAK-1 kinases to treat inflammatory disorders.

A composition combining NARH and NR precursors increases intracellular NAD+ levels through synergistic biosynthesis pathways.

Overexpressing miR-144 in host cells increases viral titers while simplifying manufacturing complexity.

Extracting serovar hardjo reduces vaccine components while maintaining cross-protective efficacy against leptospirosis.

Specific bacterial compositions prime the immune system to generate IFN-gamma producing CD8+ T cells, addressing limited efficacy in cancer immunotherapy.

Attenuated Edwardsiella bacterium elicits immune response in fish, protecting against multiple pathogens while reducing injection costs.

Capsaicyn derivatives block quorum sensing signals to treat leaky gut syndrome without disrupting the gut microbiota balance.

Keto fatty acid formulations modulate inflammatory responses while reducing toxic side effects associated with conventional COX-2 inhibitors.

A heat shock protein fused to a biotin-binding protein enables rapid assembly of biotinylated antigens into stable vaccine complexes.

Heterocyclic derivatives inhibit plasma kallikrein selectively, resolving the trade-off between oral bioavailability and enzyme specificity.

Replacing flammable isopropyl alcohol, a fluorescent microemulsion provides non-flammable skin prep with UV-visible compliance monitoring.

A synthetic saccharide conjugate elicits protective antibodies against Klebsiella pneumoniae serotypes.

BP-2a and spb1 polypeptides replace traditional carriers to boost protective immunity against Group B Streptococcus strains.

Microbial deoxyribonucleases degrade extracellular DNA within biofilms to disrupt structural integrity and prevent formation.

Selective S1PR3 antagonists blunt pro-inflammatory mediators to mitigate sepsis severity and reduce organ damage.

Substituted 1,3,4-oxadiazole derivatives inhibit growth of multi-drug resistant Mycobacterium tuberculosis strains at micromolar concentrations.

Combining zinc pyrithione and silver sulfadiazine creates a synergistic antimicrobial composition.

A.C.C. herbal extract inhibits nitric oxide production and inflammatory cytokine expression to treat skin irritations.

A pharmaceutical composition combining vitamin C, zinc, and Echinacea to stimulate the immune system.

Guanidinoglycoside conjugates bind cell surface proteoglycans to transport therapeutic proteins across the blood-brain barrier.

Dual inhibition of RNase P and tRNA synthetase overcomes mupirocin resistance in Staphylococcus aureus, enabling effective decolonization.

External nitric oxide donors or internal metabolism blockage reduce pyocyanin production and flagellar movement without harming normal flora.

Novel 6-substituted isoquinoline derivatives inhibit Rho-kinase activity through specific structural modifications.

A composite IgM protease antigen formulation overcomes limited homologous protection in conventional bacterin vaccines by inducing robust heterologous immunity.

An antibacterial composition using quaternary ammonium compounds, alkamine oxides, and nonionic materials reduces eye irritation while maintaining efficacy.

Novel amino pyridine derivatives target the PI 3-kinase gamma isoform to block enzymatic activity.